- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 09-02-2026: Press Release
09-02-2026 | 01:31 pm
09-02-2026 | 01:31 pm
Zydus Lifesciences posted strong Q3 results: Revenue up 30% to ₹6,864.5 Cr, EBITDA up 31% to ₹1,816.4 Cr, Net Profit up 9% to ₹1,110.9 Cr. Growth driven by Consumer Wellness & International Markets. Launched new oncology product, secured USFDA rare disease approval, and acquired biosimilar rights.
No comments yet. Be the first to comment!